← Leaderboards
Matthew Kirkby
Ppd Development Lp
$20,666,773
Attributed
$20,666,773
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.4M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,666,773 · 7
By mechanism
N01$20,437,908 · 5
N02$228,865 · 2
Top collaborators
No co-investigators on record.
Most similar at Ppd Development Lp
Same institution · by research overlap
- Charity-Anne Schuller$22,069,318
- Jaikrishna Balkissoon$15,000
- Craig Boyle$2,773,098
Others in their field
Top investigators on “Services”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,236,423,805
- Leonard Freedman · Leidos Biomedical Research, Inc.$868,224,440
- Larry Arthur$689,089,782
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
ServicesProgramsContractsClinical ResearchClinical TrialsFundingCommunicable DiseasesRegulatory AffairsContractorResearch PersonnelPrincipal InvestigatorU-Series Cooperative AgreementsGrantConduct Clinical TrialsFutureClinical Research SiteIndustry CollaborationProtocol DevelopmentPhase I Clinical TrialsMethod DevelopmentDatabasesDoseDedicationsPre-Clinical
Grant awards (15)
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases$2,947,889
N01 · FY2025 · AI · contact PI
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases$3,316,430
N01 · FY2024 · AI · contact PI
CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. REGULATORY PATHWAY AND MARKET ACCESS SUPPORT. TASK ORDER 03. 04/09/2024 - 04/$169,638
N02 · FY2024 · DA · contact PI
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases$4,197,535
N01 · FY2023 · AI · contact PI
THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE)$2,330,011
N01 · FY2022 · AI · contact PI
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases$1,992,740
N01 · FY2022 · AI · contact PI
REGULATORY MANAGEMENT CENTER (RMC)$1,091,631
N01 · FY2022 · AI · contact PI
REGULATORY MANAGEMENT CENTER (RMC)$1,000,000
N01 · FY2022 · AI · contact PI
CLINICAL CENTRAL LABORATORY SERVICES$25,000
N01 · FY2021 · AI · contact PI
BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION$1,705,990
N01 · FY2020 · DA · contact PI
FY19 TRIAL EXECUTION OPTION ITEM #2 - KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR C$476,848
N01 · FY2020 · DA · contact PI
FY19 TRIAL EXECUTION OPTION ITEM #2 - KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR C$954,796
N01 · FY2019 · NS · contact PI
BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION$387,029
N01 · FY2019 · NS · contact PI
Task F01: Non-clinical Services for Development of Interventional Agents for Infectious Diseases$12,009
N01 · FY2018 · AI · contact PI
Cancer Trials Support Unit(CTSU), Exceptional Responders Initiative$59,227
N02 · FY2014 · CA · contact PI